Ready to play
Ready to play
A study at the University of Cambridge has shown that a vaccine fully developed using artificial intelligence and administered to humans achieved limited results in boosting immunity, as it did not produce a significant increase in antibody response among participants. This is considered the first of its kind, created by algorithms based on the genetic data of coronavirus variants, with the aim of predicting virus evolution and avoiding the need to develop updated vaccines periodically. Despite these disappointing results, it was confirmed that the vaccine did not cause serious side effects, paving the way for broader trials in the future.
Notice: This Is an AI-Generated Summary
Comments (0)